Clinical Trials Update:&nbsp;Nov. 17, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
501426
WEDNESDAY, Aug. 18  (HealthDayNews) -- A new blood test holds promise for improving the treatment of advanced breast cancer, researchers report.
310131
Aventis, part of the sanofi-aventis Group (EURONEXT: SAN), announced today that The New England Journal of Medicine has published the results of two landmark phase III studies, which demonstrate that Taxotere (docetaxel) Injection Concentrate-based
643185
FRIDAY, Sept. 15 (HealthDay News) -- Researchers may be able to determine the effectiveness of anti-angiogenic cancer drugs by measuring levels of a type of blood cell.
588883
roundup Plus: Rice lab makes nano parts less toxic...TV chip company gets $19 million...Oracle extends deadline on PeopleSoft bid...MLB sells game clips for 99 cents.
438501
Here's what a newly approved drug looks like.
500493
SATURDAY, Jan. 29 (HealthDayNews) -- A new drug that targets pancreatic cancer in two ways is being tested by oncologists at the University of Southern California/Norris Comprehensive Cancer Center.
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
117982
Robert B. Saper, MD, MPH ; Stefanos N. Kales, MD, MPH ; Janet Paquin, PhD ; Michael J. Burns, MD ; David M. Eisenberg, MD ; Roger B. Davis, ScD ; Russell S. Phillips, MD.
273621
Pfizer Inc&#39;s experimental oral  biotechnology drug axitinib demonstrated substantial anti-tumor  activity in patients with advanced thyroid cancer in a small,  mid-stage clinical trial, according to data released at a major  cancer meeting on Saturday.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
671952
THURSDAY, Jan. 27 (HealthDayNews) -- The results of a multi-center trial involving a quartet of drugs may bring fresh hope to patients battling advanced colorectal cancer, researchers reported Thursday.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
197909
roundup Plus: IBM gives grants to universities...Sun expands pay-as-you go supercomputing...SGI works on Linux performance software.